Author: Smead Capital Management

WSJ: Bill Smead on the Fed’s Interest Rate Hike

Rate Liftoff Gives a Boost to U.S. Stocks By Sarah Krouse and Katy Burne For more information go to www.wsj.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee

⟶ Keep Reading

Stock Market Control

We make no effort at Smead Capital Management to have any control over stock market results, volatility, unpredictability and relative performance. We haven’t got any special ability to know what stocks will do next year or how we will fare on a relative basis. What we do try to control is what we own, how cheap it is, how often we make changes to our portfolio (we subscribe to “lethargy bordering on sloth”—Warren Buffett) and what kind of quality we demand from the companies we buy and own.

⟶ Keep Reading

CNBC Closing Bell: Bill Smead on Dividends

How to handle your dividend stocks Hosted by Kelly Evans Bill Griffeth For more information go to www.cnbc.com. Stocks mentioned: None The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is

⟶ Keep Reading

Historical Rates Impact Common Stocks

Time and coincidence often cloud our own perception. Consider interest rates. Most Baby Boomers and Generation Xers became adults (21 or older) between 1965 and 2005. During that period, these adults witnessed an aberration in the history of interest rates—monumental highs (20%) and levels consistently above historical norms.

⟶ Keep Reading

Drilling for Oil on Wall Street

As long-duration common stock owners and investors, we focus on our bottoms-up stock picking and seek to analyze the micro-economics of each industry involved. However, the importance of oil prices to the economy of the U.S. and its effect on inflation helps determine the intrinsic value of our companies. While we currently own no energy companies in our portfolio, we would like to pause and see what the rhymes of history can tell us about the circumstances of today.

⟶ Keep Reading

Bloomberg: Bill Smead on Amgen’s earnings

Amgen Posts Profit That Tops Estimates, Raises Guidance By Caroline Chen & Doni Bloomfield For more information go to www.bloomberg.com. Stock’s Mentioned: AMGN The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is

⟶ Keep Reading

Reuters: Tony Scherrer discusses Pharma Earnings

Top U.S. drugmakers ride new products to strong results By Bill Berkrot and Ransdell Pierson   For more information go to www.reuters.com. Stocks mentioned: None The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice.

⟶ Keep Reading

3Q15 Newsletter: Red Room, Green Room, and Beige Room

One of the great investing books of the last 40 years was David Dreman’s, Contrarian Investment Strategy. He started it by telling of a hypothetical gaming casino with two separate, but adjoining, rooms: the red room and the green room. The red room was packed with people and excitement and almost every day someone hit a huge jackpot setting the building on fire with electricity. Every seat was packed, others waited their turn to play and the anticipation was palpable. Yet most of the players left the casino each night without their money, because the odds were stacked heavily in the house’s favor.

⟶ Keep Reading

CNBC Squawk Box: Bill Smead on the US economy and housing

Booming economy would kill bull market Closing Bell hosted Becky Quick and Joe Kernen For the full story, go to www.cnbc.com.       The information contained in this tv appearance represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance

⟶ Keep Reading
Scroll to Top